Global Crohn's Disease Market, By Procedures (Colonoscopy, Flexible Sigmoidoscopy, Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), Capsule Endoscopy, Double-Balloon Endoscopy, Small Bowel Imaging), Therapeutic type (Non-surgical, Surgical), End User (Hospitals and Clinics, Research Institutes, Diagnostic Centres and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Crohn's Disease Market
Rising awareness about the disease coupled with rising initiatives by the government for novel treatment options are attributable to the growth of crohn’s disease market. Data Bridge Market Research analyses that the non-small cell lung cancer will exhibit a CAGR of around 3.7% for the forecast period of 2021-2028.
Crohn’s disease, also known as inflammatory bowel disease (IBD), affects the lining of digestive tract. Crohn’s disease is a long term inflammation of both small and large intestines. It can lead to diarrhoea, abdominal pain, weight loss, fatigue and malnutrition. It is a rare disease caused by a combination of factors such as overactive immune system, genetics, bad eating habits and other environmental factors.
Rising prevalence of crohn’s disease is bolstering the growth of its treatment procedures and apparatuses. Rising collaboration of major key players with the regulatory bodies and research institutes to develop novel treatment options is also fostering the growth of the market. Also, preference of symptomatic medicines over surgeries will steer the industry trends.
However, expensive treatment of crohn’s disease will pose a major challenge to the market. Patent expiry of drugs will further slowdown the market growth rate. Lack of early diagnosis technology will also create hindrances in the way of market growth.
This crohn’s disease market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on crohn’s disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Crohn's Disease Market Scope and Market Size
- The crohn’s disease market is segmented on the basis of procedures, therapeutic type, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the procedures, the crohn’s disease market has been segmented into colonoscopy, flexible sigmoidoscopy, computerized tomography (CT), magnetic resonance imaging (MRI), capsule endoscopy, double-balloon endoscopy and small bowel imaging.
- Based on the therapeutic type, the crohn’s disease market has been segmented into non-surgical and surgical. Non-surgical segmented into corticosteroids, oral 5-aminosalicylates, azathioprine, mercaptopurine, TNF inhibitors, methotrexate, natalizumab, vedolizumab, ustekinumab, anti-inflammatory, immune system suppressors and antibiotics.
- On the basis of end user, the crohn’s disease market is segmented into hospitals and clinics, research institutes, diagnostic centres and others.
- On the basis of distribution channel, the crohn’s disease market is segmented into direct hospital pharmacy, retail pharmacy, online and others.
Core Crohn's Disease Market Country Level Analysis
The crohn’s disease market is analysed and market size insights and trends are provided by country, procedures, therapeutic type, end user and distribution channel as referenced above.
The countries covered in the crohn’s disease market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the crohn’s disease market owing to the prevalence of sophisticated healthcare infrastructure, increased research and development proficiencies by the pharmaceutical companies and rapid adoption of new and better healthcare technologies. Rising prevalence of gastrointestinal diseases is also steering the industry trends in this region. Asia-Pacific on the other hand is projected to score highest growth rate for the forecast period owing to rising expenditure to develop healthcare infrastructure coupled with rising involvement of regulatory bodies for research and development activities.
The country section of the crohn’s disease market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The crohn’s disease market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for clinical trial imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the crohn’s disease market. The data is available for historic period 2010 to 2019.Competitive Landscape and Crohn's disease market Share Analysis
The crohn’s disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to core crohn’s disease market.
The major players covered in the crohn’s disease market report are GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Novartis AG, Eli Lilly And Company., Astrazeneca, Pfizer Inc., Takeda Pharmaceutical Company Limited., Bristol-Myers Squibb Company, Sanofi, Johnson & Johnson Services, Inc., Bayer AG, AbbVie Inc., Allergan, Janssen Global Services, LLC, Takeda Pharmaceutical Company Limited, UCB S.A., Ferring B.V., Tillotts Pharma AG, Merck & Co., Inc. and Amgen Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-